These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24445350)

  • 1. Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network.
    Shiva Shankar TV; Willems L
    Vascul Pharmacol; 2014 Feb; 60(2):57-66. PubMed ID: 24445350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic modulation by small molecule compounds for neurodegenerative disorders.
    Singh AK; Halder-Sinha S; Clement JP; Kundu TK
    Pharmacol Res; 2018 Jun; 132():135-148. PubMed ID: 29684672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic effects of antiangiogenic drugs in tumors: therapeutic implications.
    Quintieri L; Selmy M; Indraccolo S
    Biochem Pharmacol; 2014 May; 89(2):162-70. PubMed ID: 24607274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
    Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
    Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of epigenetic regulation in myocardial ischemia/reperfusion injury.
    Wang K; Li Y; Qiang T; Chen J; Wang X
    Pharmacol Res; 2021 Aug; 170():105743. PubMed ID: 34182132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutive activation of the ATM/BRCA1 pathway prevents DNA damage-induced apoptosis in 5-azacytidine-resistant cell lines.
    Imanishi S; Umezu T; Ohtsuki K; Kobayashi C; Ohyashiki K; Ohyashiki JH
    Biochem Pharmacol; 2014 Jun; 89(3):361-9. PubMed ID: 24680865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
    Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
    J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting epigenetic and post-translational modifications regulating pyroptosis for the treatment of inflammatory diseases.
    Ri-Wen ; Yang YH; Zhang TN; Liu CF; Yang N
    Pharmacol Res; 2024 May; 203():107182. PubMed ID: 38614373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-engineered 3D tumor angiogenesis models: potential technologies for anti-cancer drug discovery.
    Chwalek K; Bray LJ; Werner C
    Adv Drug Deliv Rev; 2014 Dec; 79-80():30-9. PubMed ID: 24819220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.
    Zhang Y; Fatima N; Dufau ML
    Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine.
    Nguyen CT; Weisenberger DJ; Velicescu M; Gonzales FA; Lin JC; Liang G; Jones PA
    Cancer Res; 2002 Nov; 62(22):6456-61. PubMed ID: 12438235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein acetylation and related potential therapeutic strategies in kidney disease.
    Li XY; Yu JT; Dong YH; Shen XY; Hou R; Xie MM; Wei J; Hu XW; Dong ZH; Shan RR; Jin J; Shao W; Meng XM
    Pharmacol Res; 2023 Nov; 197():106950. PubMed ID: 37820854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.
    Zhong S; Fields CR; Su N; Pan YX; Robertson KD
    Oncogene; 2007 Apr; 26(18):2621-34. PubMed ID: 17043644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells.
    Lee SH; Kim J; Kim WH; Lee YM
    Oncogene; 2009 Jan; 28(2):184-94. PubMed ID: 18850007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unravelling the impact of RNA methylation genetic and epigenetic machinery in the treatment of cardiomyopathy.
    Liu L; Yu L; Wang Y; Zhou L; Liu Y; Pan X; Huang J
    Pharmacol Res; 2024 Sep; 207():107305. PubMed ID: 39002868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of clusterin/apolipoprotein J expression in retinal pigment epithelial cells.
    Suuronen T; Nuutinen T; Ryhänen T; Kaarniranta K; Salminen A
    Biochem Biophys Res Commun; 2007 Jun; 357(2):397-401. PubMed ID: 17420006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of development by histone lysine methylation.
    Dambacher S; Hahn M; Schotta G
    Heredity (Edinb); 2010 Jul; 105(1):24-37. PubMed ID: 20442736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic regulation of endometrium during the menstrual cycle.
    Munro SK; Farquhar CM; Mitchell MD; Ponnampalam AP
    Mol Hum Reprod; 2010 May; 16(5):297-310. PubMed ID: 20139117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.